戻る
Alpha Cognition Inc (ACOG)価格
ACOG 株価推移チャート
ACOG 収入
Alpha Cognition Inc
$5.72
-1.71%
$-0.1
終値： Jan 16, 16:00:00 GMT-5
$5.72
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$5.82
始値
$5.68
当日レンジ
$5.66 - $5.94
52週レンジ
$3.75 - $11.54
取引高
90.1K
平均取引高
94.9K
1株当たり利益(TTM)
-1.37
配当利回り
--
時価総額
$124.3M
ACOGとは何ですか？
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company is headquartered in Vancouver, British Columbia and currently employs 52 full-time employees. The company went IPO on 2021-06-09. The firm's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.